132 related articles for article (PubMed ID: 27346312)
1. [Early-onset and late-onset male hypogonadotropic hypogonadism and osteoporosis].
Okada H; Shin T; Kobori Y
Clin Calcium; 2016 Jul; 26(7):1009-16. PubMed ID: 27346312
[TBL] [Abstract][Full Text] [Related]
2. Male hypogonadism and skeletal health.
Irwig MS
Curr Opin Endocrinol Diabetes Obes; 2013 Dec; 20(6):517-22. PubMed ID: 24468754
[TBL] [Abstract][Full Text] [Related]
3. Late-onset hypogonadism.
Bassil N
Med Clin North Am; 2011 May; 95(3):507-23, x. PubMed ID: 21549875
[TBL] [Abstract][Full Text] [Related]
4. Late-onset hypogonadism and lifestyle-related metabolic disorders.
Braga PC; Pereira SC; Ribeiro JC; Sousa M; Monteiro MP; Oliveira PF; Alves MG
Andrology; 2020 Nov; 8(6):1530-1538. PubMed ID: 31991053
[TBL] [Abstract][Full Text] [Related]
5. Bone health in hypogonadal men.
Irwig MS
Curr Opin Urol; 2014 Nov; 24(6):608-13. PubMed ID: 25144148
[TBL] [Abstract][Full Text] [Related]
6. Hypotestosteronaemia in the aging male: should we treat it?
Christe N; Meier CA
Swiss Med Wkly; 2015; 145():w14216. PubMed ID: 26599486
[TBL] [Abstract][Full Text] [Related]
7. Site-specific effect of testosterone on bone mineral density in male hypogonadism.
Choi HR; Lim SK; Lee MS
J Korean Med Sci; 1995 Dec; 10(6):431-5. PubMed ID: 8924228
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor concentrations in seminal plasma from patients with hypogonadism--changes after hormone replacement.
Fuse H; Okumura M; Sakamoto M; Kazama T; Katayama T
Urol Int; 1994; 52(1):9-13. PubMed ID: 8140686
[TBL] [Abstract][Full Text] [Related]
9. Effects of gonadotropin and testosterone treatments on Lipoprotein(a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism.
Ozata M; Yildirimkaya M; Bulur M; Yilmaz K; Bolu E; Corakci A; Gundogan MA
J Clin Endocrinol Metab; 1996 Sep; 81(9):3372-8. PubMed ID: 8784099
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo androgen regulation of Dendropanax morbiferus leaf extract on late-onset hypogonadism.
Jung MA; Oh KN; Choi EJ; Oh DR; Kim YJ; Bae D; Hong JA; Pan S; Kim KM; Kim DW; Choi CY
Cell Mol Biol (Noisy-le-grand); 2018 Jul; 64(10):20-27. PubMed ID: 30084791
[TBL] [Abstract][Full Text] [Related]
11. Assessment and management of male androgen disorders: an update.
Chan I; Fui MN; Zajac JD; Grossmann M
Aust Fam Physician; 2014 May; 43(5):277-82. PubMed ID: 24791767
[TBL] [Abstract][Full Text] [Related]
12. Plasma insulin-like factor 3 (INSL3) in male patients with osteoporosis and Klinefelter's syndrome.
Hussain A; Swaminathan R; Sankaralingam A; Carroll PV; Hampson G; McGowan BM
Ital J Anat Embryol; 2013; 118(1 Suppl):34-6. PubMed ID: 24640568
[TBL] [Abstract][Full Text] [Related]
13. Androgen replacement therapy in late-onset hypogonadism: current concepts and controversies - a mini-review.
Mäkinen JI; Huhtaniemi I
Gerontology; 2011; 57(3):193-202. PubMed ID: 20689266
[TBL] [Abstract][Full Text] [Related]
14. [Late-onset hypogonadism in men: uncertain disease entity and reservations regarding treatment with testosterone].
Nieuwenhuijzen Kruseman AC
Ned Tijdschr Geneeskd; 2006 Sep; 150(35):1925-8. PubMed ID: 16999276
[TBL] [Abstract][Full Text] [Related]
15. [Role of androgen in the elderly. Clinical androgen replacement therapy for late-onset hypogonadism].
Amano T
Clin Calcium; 2013 Aug; 23(8):1179-84. PubMed ID: 23892219
[TBL] [Abstract][Full Text] [Related]
16. Bone benefits of testosterone replacement therapy in male hypogonadism.
Tirabassi G; Biagioli A; Balercia G
Panminerva Med; 2014 Jun; 56(2):151-63. PubMed ID: 24994579
[TBL] [Abstract][Full Text] [Related]
17. [Effect on phospho-calcium metabolism of testosterone administration in hypogonadal males].
Salamano G; Isaia GC; Pecchio F; Appendino S; Mussetta M; Molinatti GM
Arch Ital Urol Nefrol Androl; 1990 Mar; 62(1):149-53. PubMed ID: 2141708
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological management of late-onset hypogonadism.
Rastrelli G; Maggi M; Corona G
Expert Rev Clin Pharmacol; 2018 Apr; 11(4):439-458. PubMed ID: 29505313
[TBL] [Abstract][Full Text] [Related]
19. [Bone and Men's Health. Androgen replacement therapy and bone metabolism].
Ogawa S
Clin Calcium; 2010 Feb; 20(2):251-7. PubMed ID: 20118518
[TBL] [Abstract][Full Text] [Related]
20. Effects of long-acting testosterone undecanoate on bone mineral density in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 36 months controlled study.
Aversa A; Bruzziches R; Francomano D; Greco EA; Fornari R; Di Luigi L; Lenzi A; Migliaccio S
Aging Male; 2012 Jun; 15(2):96-102. PubMed ID: 22439807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
